Relationship between ABO Blood Group Distribution and COVID-19 Infection in Patients Admitted to the ICU: A Multicenter Observational Spanish Study

Since the beginning of the COVID-19 pandemic in December 2019, a relationship between the ABO blood group type and the novel coronavirus SARS-CoV-2, the etiological agent of COVID-19, has been reported, noting that individuals with the O blood group are the least likely to be infected. Spain is one...

Descripción completa

Detalles Bibliográficos
Autores: Jerico, C, Zalba-Marcos, S, Quintana-Diaz, M, Lopez-Villar, O, Santolalla-Arnedo, I, Abad-Motos, A, Laso-Morales, MJ, Sancho, E, Subira, M, Bassas, E, de Vinaspre-Hernandez, RR, Juarez-Vela, R, Garcia-Erce, JA
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2022
País:España
Institución:Institut d'Investigació i Innovació Parc Taulí (I3PT)
Repositorio:r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
OAI Identifier:oai:i3pt.fundanetsuite.com:p1332
Acceso en línea:https://i3pt.portalinvestigacion.com/publicaciones/1332
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85130689538&doi=10.3390%2fjcm11113042&partnerID=40&md5=9c8e278ed42fba25fc0c66834291bea6
Access Level:acceso abierto
Palabra clave:ABO blood-group system
coronavirus infections
multivariate analysis
id ES_db8024fd81318fc18910f73ab2b39fca
oai_identifier_str oai:i3pt.fundanetsuite.com:p1332
network_acronym_str ES
network_name_str España
repository_id_str
spelling Relationship between ABO Blood Group Distribution and COVID-19 Infection in Patients Admitted to the ICU: A Multicenter Observational Spanish StudyJerico, CZalba-Marcos, SQuintana-Diaz, MLopez-Villar, OSantolalla-Arnedo, IAbad-Motos, ALaso-Morales, MJSancho, ESubira, MBassas, Ede Vinaspre-Hernandez, RRJuarez-Vela, RGarcia-Erce, JAABO blood-group systemcoronavirus infectionsmultivariate analysisSince the beginning of the COVID-19 pandemic in December 2019, a relationship between the ABO blood group type and the novel coronavirus SARS-CoV-2, the etiological agent of COVID-19, has been reported, noting that individuals with the O blood group are the least likely to be infected. Spain is one of the most badly affected countries worldwide, with high rates of patients diagnosed, hospitalized, and deceased due to COVID-19 infection. The present study aimed to analyze the possible relationship of ABO in COVID-19 patients hospitalized in different Spanish centers during the first wave of the COVID-19 pandemic, for which the ABO group was available. Physicians from the transfusion services of different Spanish hospitals, who have developed a multicenter retrospective observational study, were invited to participate voluntarily in the research and 12,115 patients with COVID-19 infection were admitted to the nine participating hospitals. The blood group was known in 1399 cases (11.5%), of which 365 (26.1%) were admitted to the ICU. Regarding the distribution of ABO blood groups, a significant increase in the non-O blood groups and reduction for the O blood group was observed in patients hospitalized due to COVID-19, compared to the reference general population. Among the patients admitted to the ICU, after multivariate analysis, adjusted for the rest of the confounding variables, patients with the O blood group presented a significantly lower risk for admission to the ICU. We conclude that an association was observed between patients with the O blood group and their lower susceptibility to SARS-CoV-2 infection, both for those admitted to the hospitalization ward and for those who required admission to the ICU.MDPI2022info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://i3pt.portalinvestigacion.com/publicaciones/1332https://www.scopus.com/inward/record.uri?eid=2-s2.0-85130689538&doi=10.3390%2fjcm11113042&partnerID=40&md5=9c8e278ed42fba25fc0c66834291bea6Journal of Clinical MedicineISSN: 20770383reponame:r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulíinstname:Institut d'Investigació i Innovació Parc Taulí (I3PT)Inglésinfo:eu-repo/semantics/openAccessoai:i3pt.fundanetsuite.com:p13322026-06-21T15:30:37Z
dc.title.none.fl_str_mv Relationship between ABO Blood Group Distribution and COVID-19 Infection in Patients Admitted to the ICU: A Multicenter Observational Spanish Study
title Relationship between ABO Blood Group Distribution and COVID-19 Infection in Patients Admitted to the ICU: A Multicenter Observational Spanish Study
spellingShingle Relationship between ABO Blood Group Distribution and COVID-19 Infection in Patients Admitted to the ICU: A Multicenter Observational Spanish Study
Jerico, C
ABO blood-group system
coronavirus infections
multivariate analysis
title_short Relationship between ABO Blood Group Distribution and COVID-19 Infection in Patients Admitted to the ICU: A Multicenter Observational Spanish Study
title_full Relationship between ABO Blood Group Distribution and COVID-19 Infection in Patients Admitted to the ICU: A Multicenter Observational Spanish Study
title_fullStr Relationship between ABO Blood Group Distribution and COVID-19 Infection in Patients Admitted to the ICU: A Multicenter Observational Spanish Study
title_full_unstemmed Relationship between ABO Blood Group Distribution and COVID-19 Infection in Patients Admitted to the ICU: A Multicenter Observational Spanish Study
title_sort Relationship between ABO Blood Group Distribution and COVID-19 Infection in Patients Admitted to the ICU: A Multicenter Observational Spanish Study
dc.creator.none.fl_str_mv Jerico, C
Zalba-Marcos, S
Quintana-Diaz, M
Lopez-Villar, O
Santolalla-Arnedo, I
Abad-Motos, A
Laso-Morales, MJ
Sancho, E
Subira, M
Bassas, E
de Vinaspre-Hernandez, RR
Juarez-Vela, R
Garcia-Erce, JA
author Jerico, C
author_facet Jerico, C
Zalba-Marcos, S
Quintana-Diaz, M
Lopez-Villar, O
Santolalla-Arnedo, I
Abad-Motos, A
Laso-Morales, MJ
Sancho, E
Subira, M
Bassas, E
de Vinaspre-Hernandez, RR
Juarez-Vela, R
Garcia-Erce, JA
author_role author
author2 Zalba-Marcos, S
Quintana-Diaz, M
Lopez-Villar, O
Santolalla-Arnedo, I
Abad-Motos, A
Laso-Morales, MJ
Sancho, E
Subira, M
Bassas, E
de Vinaspre-Hernandez, RR
Juarez-Vela, R
Garcia-Erce, JA
author2_role author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv ABO blood-group system
coronavirus infections
multivariate analysis
topic ABO blood-group system
coronavirus infections
multivariate analysis
description Since the beginning of the COVID-19 pandemic in December 2019, a relationship between the ABO blood group type and the novel coronavirus SARS-CoV-2, the etiological agent of COVID-19, has been reported, noting that individuals with the O blood group are the least likely to be infected. Spain is one of the most badly affected countries worldwide, with high rates of patients diagnosed, hospitalized, and deceased due to COVID-19 infection. The present study aimed to analyze the possible relationship of ABO in COVID-19 patients hospitalized in different Spanish centers during the first wave of the COVID-19 pandemic, for which the ABO group was available. Physicians from the transfusion services of different Spanish hospitals, who have developed a multicenter retrospective observational study, were invited to participate voluntarily in the research and 12,115 patients with COVID-19 infection were admitted to the nine participating hospitals. The blood group was known in 1399 cases (11.5%), of which 365 (26.1%) were admitted to the ICU. Regarding the distribution of ABO blood groups, a significant increase in the non-O blood groups and reduction for the O blood group was observed in patients hospitalized due to COVID-19, compared to the reference general population. Among the patients admitted to the ICU, after multivariate analysis, adjusted for the rest of the confounding variables, patients with the O blood group presented a significantly lower risk for admission to the ICU. We conclude that an association was observed between patients with the O blood group and their lower susceptibility to SARS-CoV-2 infection, both for those admitted to the hospitalization ward and for those who required admission to the ICU.
publishDate 2022
dc.date.none.fl_str_mv 2022
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://i3pt.portalinvestigacion.com/publicaciones/1332
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85130689538&doi=10.3390%2fjcm11113042&partnerID=40&md5=9c8e278ed42fba25fc0c66834291bea6
url https://i3pt.portalinvestigacion.com/publicaciones/1332
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85130689538&doi=10.3390%2fjcm11113042&partnerID=40&md5=9c8e278ed42fba25fc0c66834291bea6
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv MDPI
publisher.none.fl_str_mv MDPI
dc.source.none.fl_str_mv Journal of Clinical Medicine
ISSN: 20770383
reponame:r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
instname:Institut d'Investigació i Innovació Parc Taulí (I3PT)
instname_str Institut d'Investigació i Innovació Parc Taulí (I3PT)
reponame_str r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
collection r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869421681545576448
score 15.812429

Similares en LA Referencia